Navigation Links
New drug for hypertension

The National Chemical Laboratory (NCL) and Emcure Pharmaceuticals Ltd, a Pune-based company have jointly come out with a new drug for the treatment of hypertension. Announcing this at a press conference here on Thursday,// NCL director Sivaram and Emcure managing director Satish Mehta said the chirally pure S-Amlodipine, a product of their collaborative research, will be a great boon for the patients suffering from hypertension.

Stating that Emcure is among the first few in the world to introduce this product, they said the company has been granted permission from Drug Controller General of India for the manufacture of both bulk as well as formulations of S-Amlodipine.

Although Amlodipine is a proven therapy for the treatment of hypertension, it is commonly associated with side effects like headache, dizziness, flusing and abdominal pain, they said.But clinical study of S-Amlodipine has shown that none of the patients in the treatment group reported any such side effects, they said adding, NCL has already filed Indian and foreign patent applications. S-Amlodipine is the first of many more chirally pure drugs on which the NCL and Emcure scientists are working, they added.


'"/>




Page: 1

Related medicine news :

1. Preventing white coat hypertension
2. Risk of dementia reduced hypertension drugs
3. An hour of exercise a week cuts hypertension
4. Drug used to treat hypertension effective in countering Migraines
5. Common, cheaper drugs could be used to treat hypertension
6. Evidence against use of Beta blockers as first choice in the treatment of primary hypertension
7. Healthy lifestyle reduces the risk of developing hypertension
8. Prehypertension in the Young Leads to Hypertensive Adults
9. Hypertension, Prehypertension in Youngsters Linked With Heart Enlargement
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
Breaking Medicine Technology: